In The Future, CRISPR And CAS Gene Therapies May Be Used To Correct Genetic Mutations That Lead To Rare Diseases
CRISPR-CAS technology has opened up new horizons in biotechnology and industrial applications. It enables the modification of microorganisms to produce valuable compounds, such as biofuels, pharmaceuticals, and enzymes. This technology also offers a promising avenue for the development of new antibiotics to combat drug-resistant bacteria. CRISPR and CAS Gene technology has revolutionized the field of disease modeling, allowing scientists to create accurate and efficient models of human diseases in the laboratory. By editing genes in stem cells or animal models, researchers can mimic the genetic mutations seen in patients and gain insights into disease mechanisms. These models serve as valuable tools for drug discovery and development, facilitating the identification of potential therapeutic targets.
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian